Information  X 
Enter a valid email address

United Drug PLC (UDG)

  Print      Mail a friend       Annual reports

Tuesday 26 July, 2011

United Drug PLC

Purchase of Own Securities

RNS Number : 0221L
United Drug PLC
26 July 2011




('United Drug' or 'the Company')


Purchase of Own Securities



United Drug announces that on 25 July 2011, its broker Davy purchased 26,964 Ordinary Shares of nominal value €0.05 each in the capital of the Company ("Ordinary Shares") on behalf of the Company. The price paid for these Ordinary Shares was €2.3812 per share.


The 26,964 Ordinary Shares will be cancelled. Following the cancellation of these shares, the Company's issued share capital will reduce from 241,278,448 to 241,251,484. Each Ordinary Share carries one vote. United Drug also holds 7,528,066 Ordinary Shares in treasury, which do not carry voting rights. 



Ends                                         26 July 2011





Karen Geoghegan

United Drug plc

Tel: +353-1-4637720



This information is provided by RNS
The company news service from the London Stock Exchange